A61K 2039/622
Non-covalent binding
Official title: {non-covalent binding}
A61K2039/622 (Non-covalent binding) appears on 159 US grants and 214 published applications in this corpus.
Search patents in A61K- Granted patents
- 159
- Published applications
- 214
- Assignees
- 113
- Inventors
- 323
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 9 | 0 |
| 2001 | 4 | 0 |
| 2002 | 20 | 14 |
| 2003 | 4 | 18 |
| 2004 | 4 | 18 |
| 2005 | 0 | 9 |
| 2006 | 3 | 8 |
| 2007 | 2 | 1 |
| 2008 | 3 | 7 |
| 2009 | 4 | 8 |
| 2010 | 1 | 6 |
| 2011 | 5 | 4 |
| 2012 | 4 | 6 |
| 2013 | 3 | 7 |
| 2014 | 5 | 4 |
| 2015 | 5 | 10 |
| 2016 | 2 | 7 |
| 2017 | 7 | 13 |
| 2018 | 4 | 9 |
| 2019 | 7 | 10 |
| 2020 | 4 | 6 |
| 2021 | 7 | 10 |
| 2022 | 5 | 11 |
| 2023 | 5 | 6 |
| 2024 | 8 | 12 |
| 2025 | 7 | 8 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Production of MHC II/CII complexes1 Sep 2026US 12,721,884 B2
- Complexes for delivery of antigenic peptides9 Jun 2026US 12,649,001 B2The Regents of the University of Michigan
- Peptide conjugated particles27 Jan 2026US 12,533,403 B2Northwestern University
- Vaccination in newborns and infants19 Aug 2025US 12,390,520 B2Cure Vac SE
- Multivalent pneumococcal vaccines5 Aug 2025US 12,377,140 B2Affinivax, Inc.
- Peptide conjugated particles24 Sep 2026US 2026/0284162 A1Northwestern University
- Binding molecule16 Jul 2026US 2026/0199502 A1
- Methods of use for car t cells4 Dec 2025US 2025/0368718 A1Endocyte, Inc.
- Vaccination in newborns and infants13 Nov 2025US 2025/0345410 A1CureVac AG
- Vaccination in newborns and infants13 Nov 2025US 2025/0345411 A1CureVac AG
Most cited
By later US patents
- Conformationally-restricted combinatiorial library composition and method117US 5,824,483 APence, Inc. · 1998
- Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy109US 5,830,464 AFordham University · 1998
- Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases108US 5,837,251 AFordham University · 1998
- Immunotherapeutic stress protein-peptide complexes against cancer102US 5,750,119 AMount Sinai School of Medicine of the City University of New York · 1998
- Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens92US 5,961,979 AMount Sinai School of Medicine of the City University of New York · 1999